Evidence-path compliance on T2D-Bench Renal medication safety
23Compliance RatioGPT-4o-mini
Evaluation Results
| Method | Links | ||
|---|---|---|---|
| GPT-4o-miniEvaluation Regime=LLM-only2026.06 | 23 | — | |
| GPT-4oEvaluation Regime=LLM-only2026.06 | 23 | — | |
| Evidence GateEvaluation Regime=Evidence-gated compliance2026.06 | 23 | — |